Interpreting the impact of hydroxychloroquine prophylaxis on SARS-CoV-2 infection

被引：0
|
作者：
Yadav, Reetika [1 ]
Madkaikar, Manisha Rajan [2 ]
机构：
[1] ICMR Natl Inst Immunohematol, Dept Pediat Immunol, Mumbai 400012, Maharashtra, India
[2] ICMR Natl Inst Immunohematol, Mumbai 400012, Maharashtra, India
来源：
INDIAN JOURNAL OF MEDICAL RESEARCH | 2021年 / 153卷 / 05期
关键词：
HEALTH-CARE WORKERS;
D O I：
10.4103/ijmr.ijmr_1092_21
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：564 / 565
页数：2
相关论文
共 50 条
  • [1] Interpreting the impact of hydroxychloroquine prophylaxis on SARS-CoV-2 infection Reply
    Gupta, Ritu
    Dwivedi, Tanima
    Gajendra, Smeeta
    Sahoo, Biswajeet
    Gupta, Sanjeev Kumar
    Vikas, H.
    Singh, Angel Rajan
    Mohan, Anant
    Bhatnagar, Sushma
    Singh, Sheetal
    Wundavalli, Laxmitej
    Guleria, Randeep
    [J]. INDIAN JOURNAL OF MEDICAL RESEARCH, 2021, 153 (05): : 565 - 567
  • [2] Hydroxychloroquine prophylaxis for SARS-CoV-2 infection among healthcare workers
    Karim, Habib M. R.
    Ahmed, Ghazal
    [J]. INDIAN JOURNAL OF MEDICAL RESEARCH, 2020, 152 (01): : 119 - +
  • [3] SARS-CoV-2 infection in a patient on chronic hydroxychloroquine therapy: Implications for prophylaxis
    Dousa, Khalid M.
    Malavade, Sharad S.
    Furin, Jennifer
    Gripshover, Barbara
    Hatszegi, Marjorie
    Hojat, Leila
    Saade, Elie
    Salata, Robert A.
    [J]. IDCASES, 2020, 20
  • [4] Summary for Patients: Postexposure Hydroxychloroquine Prophylaxis to Prevent SARS-CoV-2 Infection
    Barnabas, R., V
    Brown, E. R.
    Bershteyn, A.
    [J]. ANNALS OF INTERNAL MEDICINE, 2021, 174 (03) : I16 - I16
  • [5] Hydroxychloroquine prophylaxis for SARS-CoV-2 infection among healthcare workers Response
    Chatterjee, Pranab
    Anand, Tanu
    Singh, Kh. Jitenkumar
    Rasaily, Reeta
    Singh, Ravinder
    Das, Santasabuj
    Singh, Harpreet
    Praharaj, Ira
    Gangakhedkar, Raman R.
    Bhargava, Balram
    Panda, Samiran
    [J]. INDIAN JOURNAL OF MEDICAL RESEARCH, 2020, 152 (01): : 120 - 120
  • [6] Hydroxychloroquine as Prophylaxis for Coronavirus SARS-CoV-2 Infection: Review of the Ongoing Clinical Trials
    Galvis, Virgilio
    Spinelli, Francesca Romana
    Tello, Alejandro
    Sossa, Claudia L.
    Higuera, Juan D.
    Gomez, Edgar D.
    Serrano, Sergio E.
    Camacho, Paul A.
    Velez, Federico G.
    [J]. ARCHIVOS DE BRONCONEUMOLOGIA, 2020, 56 (09): : 606 - 608
  • [7] Chronic treatment with hydroxychloroquine and SARS-CoV-2 infection
    Ferreira, Antonio
    Oliveira-e-Silva, Antonio
    Bettencourt, Paulo
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (02) : 755 - 759
  • [8] Hydroxychloroquine in SARS-CoV-2 infection: Understanding the misadventure
    Banji, David
    Banji, Otilia J. F.
    [J]. JOURNAL OF ACUTE DISEASE, 2024, 13 (02) : 45 - 52
  • [9] Impact of hydroxychloroquine on disease progression and ICU admissions in patients with SARS-CoV-2 infection
    Awad, Nirvana
    Schiller, Daryl S.
    Fulman, Magda
    Chak, Azfar
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2021, 78 (08) : 689 - 696
  • [10] Impact of Hydroxychloroquine on Antibody Responses to the SARS-CoV-2 Coronavirus
    de Miranda Santos, Isabel Kinney Ferreira
    Costa, Carlos Henrique Nery
    [J]. FRONTIERS IN IMMUNOLOGY, 2020, 11
12345